FPH Company Description
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.
It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.
The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products.
Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers.
Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Country | New Zealand |
Founded | 1934 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 7,031 |
CEO | Lewis Gradon |
Contact Details
Address: 15 Maurice Paykel Place Auckland, 2013 New Zealand | |
Phone | 64 9 574 0100 |
Website | fphcare.com |
Stock Details
Ticker Symbol | FPH |
Exchange | New Zealand Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | NZD |
ISIN Number | NZFAPE0001S2 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Lewis Gradon | Chief Executive Officer |
Lyndal York | Chief Financial Officer |
Andy Niccol | Chief Operating Officer |
Hayden Brown | Head of Investor Relations |